| Name | Pleasant Manor Llc |
|---|---|
| Location | 27 Brand Avenue, Faribault, Minnesota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 65 |
| Occupancy Rate | 66.15% |
| Medicare ID (CCN) | 245090 |
| Legal Business Name | Pleasant Manor Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1730675919 |
| Organization Name | PLEASANT MANOR LLC |
| Address | 27 Brand Ave, Faribault, MN 55021 |
| Phone Number | 507-334-2036 |
News Archive
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
The human immune system is a brilliantly adaptable weapon against foreign invaders. But it all depends on the work of specialized cells called lymphocytes that have made a risky evolutionary gambit to mutate their own DNA.
Bruker (NASDAQ: BRKR) is showcasing a selection of innovative high-performance systems and high-value analytical solutions at Pittcon 2017 (www.pittcon.org), with an emphasis on pharma and applied markets, as well as on nano-materials research and microscopy.
New research from the University of Cincinnati College of Medicine suggests that prenatal exposure to flame retardants and perfluoroalkyl substances (PFASs) commonly found in the environment may have a lasting effect on a child's cognitive and behavioral development, known as executive function.
› Verified 5 days ago
| NPI Number | 1982607271 |
| Organization Name | PLEASANT MANOR, INC. |
| Address | 27 Brand Ave, Faribault, MN 55021 |
| Phone Number | 507-334-2036 |
News Archive
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
The human immune system is a brilliantly adaptable weapon against foreign invaders. But it all depends on the work of specialized cells called lymphocytes that have made a risky evolutionary gambit to mutate their own DNA.
Bruker (NASDAQ: BRKR) is showcasing a selection of innovative high-performance systems and high-value analytical solutions at Pittcon 2017 (www.pittcon.org), with an emphasis on pharma and applied markets, as well as on nano-materials research and microscopy.
New research from the University of Cincinnati College of Medicine suggests that prenatal exposure to flame retardants and perfluoroalkyl substances (PFASs) commonly found in the environment may have a lasting effect on a child's cognitive and behavioral development, known as executive function.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
The human immune system is a brilliantly adaptable weapon against foreign invaders. But it all depends on the work of specialized cells called lymphocytes that have made a risky evolutionary gambit to mutate their own DNA.
Bruker (NASDAQ: BRKR) is showcasing a selection of innovative high-performance systems and high-value analytical solutions at Pittcon 2017 (www.pittcon.org), with an emphasis on pharma and applied markets, as well as on nano-materials research and microscopy.
New research from the University of Cincinnati College of Medicine suggests that prenatal exposure to flame retardants and perfluoroalkyl substances (PFASs) commonly found in the environment may have a lasting effect on a child's cognitive and behavioral development, known as executive function.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 3 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.48 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 17.02 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 28.3 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.67 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.6 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.6 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.8 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.4 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.97 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.48 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.26 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 36.04 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 7.37 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.19 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 89.47 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 81.23 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 78.39 | 82.93 |
News Archive
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
The human immune system is a brilliantly adaptable weapon against foreign invaders. But it all depends on the work of specialized cells called lymphocytes that have made a risky evolutionary gambit to mutate their own DNA.
Bruker (NASDAQ: BRKR) is showcasing a selection of innovative high-performance systems and high-value analytical solutions at Pittcon 2017 (www.pittcon.org), with an emphasis on pharma and applied markets, as well as on nano-materials research and microscopy.
New research from the University of Cincinnati College of Medicine suggests that prenatal exposure to flame retardants and perfluoroalkyl substances (PFASs) commonly found in the environment may have a lasting effect on a child's cognitive and behavioral development, known as executive function.
› Verified 5 days ago
The Emeralds At Faribault Llc Location: 500 Southeast First Street, Faribault, Minnesota 55021 Phone: (507) 332-5100 | |